The sustainability of a community pharmacy intervention to improve the quality use of asthma medication. - Wikidata - awgldk - TriplyDB

The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.

The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.

http://www.wikidata.org/entity/Q37848882

about

Physician-pharmacist collaborative management of asthma in primary care.The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review.Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review.Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.Review of the management of childhood asthma in Tasmania.Quasi experimental designs in pharmacist intervention research.Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

P2860

Q34302094-A20EC89A-FD72-4323-BE87-3AB1FAE9E53F Q37407223-6730A35B-B1E4-4B4D-9EF2-05D65C0C33A7 Q37975523-387DA431-3F20-4BA1-ABD0-CACEF9961A85 Q38084336-00DACAFB-2C0E-42E8-9502-8BA73A6231A2 Q38112798-7FFFBD7A-4121-4D34-83A3-839CB546F2E8 Q38716354-85815E13-17A0-4751-894D-E48BDE3BA65F Q40623715-CE72101F-A48A-44EC-9E7B-C54655C4016A

P2860

The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.

http://www.wikidata.org/entity/Q37848882

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The sustainability of a commun ...... lity use of asthma medication.

@en

The sustainability of a commun ...... lity use of asthma medication.

@nl

type

label

The sustainability of a commun ...... lity use of asthma medication.

@en

The sustainability of a commun ...... lity use of asthma medication.

@nl

prefLabel

The sustainability of a commun ...... lity use of asthma medication.

@en

The sustainability of a commun ...... lity use of asthma medication.

@nl

P1433

Q37848882-A087605A-C97D-4DBC-B983-534A17131A37

P1476

Q37848882-1F934993-6259-4300-810B-E45A9AD729F9

P2093

Q37848882-39AC2A47-1AA6-493E-9C64-3C5C873937C6

Q37848882-8B545C73-41FB-4482-ADC3-2B064F8ED03F

Q37848882-A922E10F-B609-4242-950F-B0475B1D1B15

Q37848882-CE76DC05-3C3F-48D0-9779-81E0C1D70B2C

P2860

Q37848882-01E521BB-8CE0-4551-B9D2-CC6C97E6374B

Q37848882-07048082-1ED5-4EF3-951B-E3344E4BFAD8

Q37848882-1B8C5EA9-C486-43EF-96DF-6E52120F7E92

Q37848882-29340719-B1A8-4A9F-A2D6-BC700A3C5E8A

Q37848882-2BFA03AB-F894-4454-8BA5-901E4A228F3A

Q37848882-2CD1AFBC-E77F-4263-B525-BAD09C34EB7C

Q37848882-3B43A86B-228F-465E-BFAA-2331DCEEC1AC

Q37848882-3BF13712-B73D-4110-8A7A-D476774BC39C

Q37848882-5EEF289B-1358-4763-BA29-71201C2CCA55

Q37848882-BFE345E4-5F0F-42DB-9C1D-FA057E8786DA

P304

Q37848882-36502A66-6BA6-4F2B-92CC-FCFF8471A863

P31

Q37848882-B68D746A-F4E0-4C4F-BDDA-EB9B5F894F6C

P356

Q37848882-05B3A9F3-2DA0-4155-8FB1-27F1D5EE0318

P433

Q37848882-D545F73D-862E-473F-AA27-1CEF627517A3

P478

Q37848882-D1FD767A-8D1F-47D7-AF69-4AD46E9EEA94

P50

Q37848882-8B875636-3361-4A91-8286-DDB817077593

P577

Q37848882-EF1FB0D4-66A2-4A2E-8AF2-0E92429E0A9C

P5875

Q37848882-5C974BF3-855E-4781-8612-6498871D377F

P698

Q37848882-A9040F55-0DCD-4B16-A858-D1A858651979

P921

Q37848882-FA4A617B-88FF-4983-B30B-54956BE275F8

P356

J.1365-2710.2010.01165.X

P1433

Journal of Clinical Pharmacy and Therapeutics

P1476

The sustainability of a commun ...... lity use of asthma medication.

@en

P2093

E H Walters

http://www.w3.org/2001/XMLSchema#string

G Peterson

http://www.w3.org/2001/XMLSchema#string

P Gee

http://www.w3.org/2001/XMLSchema#string

S Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

The global burden of asthma: executive summary of the GINA Dissemination Committee report

The relationship between the quality of prescribing and practice appointment rates with asthma management data in those admitted to hospital due to an acute exacerbation.

Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.

Seasonality in adult asthma admissions, air pollutant levels, and climate: a population-based study.

Evaluation of asthma prescription measures and health system performance based on emergency department utilization.

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults.

Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management.

Seasonal variation in asthma-related hospital and intensive care unit admissions.

Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial.

Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma.

P304

144-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2710.2010.01165.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Bonnie J Bereznicki

P577

2010-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50265658

http://www.w3.org/2001/XMLSchema#string

P698

21366642

http://www.w3.org/2001/XMLSchema#string

P921